亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費(fèi)注冊|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

深圳石金谷科技有限公司  

化學(xué)合成原料藥、醫(yī)藥中間體、化工原料、香精香料、食品輔料、植物提取物

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
聯(lián)系方式
  • 聯(lián)系人:劉艷平
  • 電話:0755-61930350
  • 郵件:sz09@yccreate.com
  • 傳真:0755-84556470
  • QQ:2355880511
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 廠家供應(yīng)CAS號:34552-83-5禁發(fā) 鹽酸洛哌丁胺原料
廠家供應(yīng)CAS號:34552-83-5禁發(fā) 鹽酸洛哌丁胺原料
單價(jià) 面議對比
詢價(jià) 暫無
發(fā)貨 廣東深圳市付款后3天內(nèi)
品牌 南箭
型號 34552-83-5
規(guī)格 醫(yī)藥級
過期 長期有效
更新 2013-08-13 11:01
 
詳細(xì)信息
廠家供應(yīng)CAS號:34552-83-5禁發(fā) 鹽酸洛哌丁胺原料
禁發(fā) 鹽酸洛哌丁胺

中文名稱: 禁發(fā) 鹽酸洛哌丁胺
英文名稱: Loperamide hydrochloride
英文同義詞: LABOTEST-BB LT00134703;LOSERAMIN;LOPERAMIDE HCL;LOPERAMIDE HYDROCHLORIDE;4-(4-CHLOROPHENYL)-4-HYDROXY-N,N-DIMETHYL-ALPHA,ALPHA-DIPHENYL-1-PIPERIDINBUTYRAMIDE HYDROCHLORIDE;4-(4-CHLOROPHENYL)-4-HYDROXY-N,N-DIMETHYL-ALPHA,ALPHA-DIPHENYL-1-PIPERIDINEBUTANAMIDE HYDROCHLORIDE;4-(4-chlorophenyl)-4-hydroxy-n,n-dimethyl-alpha,alpha-diphenylpiperidine-1-butyramide monohydrochloride;4-[P-CHLOROPHENYL]-4-HYDROXY-N,N-DIMETHYL-ALPHA,ALPHA-DIPHENYL-1-PIPERIDINEBUTYRAMIDE HYDROCHLORIDE
CAS號:	 34552-83-5
分子式: C29H34Cl2N2O2
分子量: 513.5
EINECS號: 252-082-4
性狀:白色結(jié)晶粉末
質(zhì)量標(biāo)準(zhǔn) :企業(yè)標(biāo)準(zhǔn)
含量 :≥98%
干燥失重:≤0.5%
用途:本品系新型抗腹瀉藥,用于控制各種急慢性功能性腹瀉,抑制腸道蠕動,從而能控制急慢性功能性腹瀉,并獲得迅速止瀉效果。
包裝: 1公斤鋁箔袋/25KG/桶

Loperamide hydrochloride 98%
Product name: Loperamide hydrochloride
Other name: LABOTEST-BB LT00134703;LOSERAMIN;LOPERAMIDE HCL
CAS No.: 34552-83-5
M.F.: C29H34Cl2N2O2
M.W.: 513.5
Assay: 98%
Packing: 1kg/foil bag
Appearance: White crystalline powder
©2025 深圳石金谷科技有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:28647  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |